Fimlab is part of a research consortium whose digital hematology project has been granted €700,000 in funding by the Research Council of Finland. The project Comprehensive AI-guided cytomorphological assessment of bone marrow investigates the use of artificial intelligence in analyzing samples from patients with blood cancers.

In addition to Fimlab, the project involves HUS and the wellbeing services county of Southwest Finland. The project is led by Docent Oscar Brück from HUS, and at Fimlab, Hematology Associate Chief Physician Samuli Rounioja serves as the responsible research lead.

Hematology is a medical specialty that studies diseases of blood and blood cells.

The project examines how well and reliably AI can support physicians in analyzing samples from patients with blood disorders. It also assesses whether the shortage of medical specialists could be alleviated by establishing a nationwide sample pool based on remote diagnostics performed by physicians.

“Diagnosing blood disorders from bone marrow samples requires experience and expertise. Our goal is for the project to enable faster and more accurate diagnostics. In pathology, AI is already used to assist cancer diagnostics, and digital pathology is clearly ahead of us. Now we have the opportunity to advance the digitalization of hematology nationwide through this project,” says Samuli Rounioja.

Read more about the research project: Kokonaisvaltainen AI-ohjattu luuytimen sytomorfologian arviointi – Tiedejatutkimus.fi.